SUPREFACT 3-MONTH DEPOT IMPLANT South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

suprefact 3-month depot implant

pharmaco distribution (pty) ltd - implant - see ingredients - each implant contains buserelin acetate equivalent to buserelin 9,45 mg

SUPREFACT DEPOT 3-MONTHS Israel - English - Ministry of Health

suprefact depot 3-months

sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).

Suprefact 1 mg/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

suprefact 1 mg/ml solution for injection

sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin

Suprefact Nasal Spray solution Malta - English - Medicines Authority

suprefact nasal spray solution

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - buserelin - nasal spray, solution - buserelin 100 µg - endocrine therapy

SUPREFACT 100 Mcg/Dose Nasal Spray Solution Ireland - English - HPRA (Health Products Regulatory Authority)

suprefact 100 mcg/dose nasal spray solution

sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues

Suprefact New Zealand - English - Medsafe (Medicines Safety Authority)

suprefact

sanofi-aventis new zealand limited - buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin - solution for injection - 1 mg/ml - active: buserelin acetate 1.05 mg/ml equivalent to 1 mg/ml buscerelin excipient: benzyl alcohol monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - for the treatment of endometriosis not primarily requiring surgical treatment. pituitary desensitisation in preparation for ovulation induction regimens using gonadotrophins.

SUPREFACT SOLUTION Canada - English - Health Canada

suprefact solution

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents

SUPREFACT SOLUTION Canada - English - Health Canada

suprefact solution

cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 1mg - buserelin (buserelin acetate) 1mg - antineoplastic agents